February 17, 2009
 |
Drugs to Watch in 2009
Experts think we’re about to enter a dry spell in terms of new HIV treatments, with no truly novel compounds available for treatment-experienced patients likely for the next several years. They remain hopeful, however, that new technologies and avenues of research could spark the next great leap forward.
|
 |
|